Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05234970 · ClinicalTrials.gov registry record · NA
iWellness Study to Evaluate a Mental Health App for Students
A NA study of Depression, Anxiety, sponsored by Harvard University.
- Completed
- Registry status
- NA
- Development phase
- 289
- Enrollment target
- 1
- Study location
NCT05234970: Completed NA study of Depression, Anxiety, sponsored by Harvard University.
NCT05234970 is a NA study of Depression, Anxiety that has completed, run by Harvard University. The registered enrollment target is 289 participants, below the 418-participant average among 40 other Depression, Anxiety trials with a reported enrollment target (31% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05234970, a NA study of Depression, Anxiety, has completed, sponsored by Harvard University.
- COMPLETED
- Registry status
- NA
- Development phase
- 289 participants
- Enrollment target
- 1
- Study location
Study Summary
The study aims to evaluate whether use of a mobile mental health app improves outcomes of depression and anxiety for students.
Primary Outcome
PHQ-9: A 9-question multipurpose instrument for screening, diagnosing, monitoring and measuring the severity of depression. Scoring: Scoring: 0-3 Scale for each item; 0 Not at all; 3 Nearly every day The nine item version of the PHQ-9 was designed to facilitate the recognition and diagnosis of depression in primary care patients. It can be used to monitor change in symptoms over time and provides a depression severity index score as follows: 0-4 None 5-9 Mild 10 - 14 Moderate 15 - 19 Moderate
Conditions Studied
Interventions
- OTHER Wysa
- OTHER Harvard College App
Study Locations (1)
Massachusetts
- Harvard University Health Services - Cambridge
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 289 participants |
| Start Date | 2022-02-24 |
| Est. Completion | 2022-12-31 |
| Phase | NA |
What the finished NCT05234970 record still lists
NCT05234970 is an interventional study that assigns participants to a tested intervention. The registered 289 participants enrollment target is mid-sized for trials with a published cap, below the 418-participant average among 40 other Depression, Anxiety trials with a reported enrollment target (31% lower).
The record links to 1 condition, with Depression, Anxiety appearing as the primary indexed condition, and to 2 interventions - of which Wysa is the first listed.
NCT05234970 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT05234970 about?
NCT05234970 is a clinical study titled "iWellness Study to Evaluate a Mental Health App for Students". The study aims to evaluate whether use of a mobile mental health app improves outcomes of depression and anxiety for students.
What is the current status of trial NCT05234970?
This trial is currently completed. It is a NA study. The enrollment target is 289 participants. The study started on 2022-02-24. Estimated completion is 2022-12-31.
What conditions does trial NCT05234970 study?
This clinical trial studies the following conditions: Depression, Anxiety.
What interventions are being tested in trial NCT05234970?
The interventions under investigation include: Wysa (OTHER), Harvard College App (OTHER).
Who is sponsoring clinical trial NCT05234970?
This trial is sponsored by Harvard University, which has 37 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05234970 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression, Anxiety
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05234970's enrollment target sits among peer trials
289 11th of 40 higher than 30 of 40 other Depression, Anxiety trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Depression, Anxiety trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Pilot Effectiveness Trial of an ACT Self-help Workbook Tailored Specifically for Prisons
RECRUITING · NA
-
Test of Target Engagement of Ambiguity Aversion
RECRUITING · NA
-
SUpport From PEeRs to Expand Access Study - Community
RECRUITING · NA
-
Building Connections
RECRUITING · NA
-
Just-In-Time Adaptive Interventions (JITAIs) in a Digital Mental Health Intervention for Middle-Aged and Older Adults With Chronic Pain
RECRUITING · NA
-
Harlem Strong Mental Health Coalition
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06465199 · 289 participants · Phase 1
Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas
- NCT00775476 · 290 participants · Phase 2
Treatment of Systemic Lupus Erythematosus (SLE) With N-acetylcysteine
- NCT01874197 · 290 participants · NA
Branched Thoracic Endovascular Grafts for the Treatment of Thoraco-abdominal Aortic
- NCT04331353 · 290 participants · NA
The Allergen Reduction and Child Health Study (ARCHS)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI